En. Esteban et al., TRANSMISSION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TO SHEEP - ANTIBODY PROFILE AND DETECTION OF VIRAL-DNA SEQUENCES, AIDS research and human retroviruses, 12(18), 1996, pp. 1717-1724
Lambs were inoculated intraperitoneally with either 1.8 x 10(7) live p
eripheral blood cells from an HTLV-I-infected person (five lambs) or w
ith 8 x 10(7) live cells from the HTLV-I-producing cell lines MT-2 (fo
ur lambs) or C10 MJ (five lambs), Four control lambs were inoculated w
ith minimal essential medium supplemented with fetal calf serum, The a
nimals were monitored during a period of 24 months, Beginning at 5 to
12 months after inoculation, four of the five lambs inoculated with th
e fresh HTLV-I-infected peripheral blood cells began to develop detect
able levels of antibodies to a recombinant HTLV-I gp21(env) antigen, a
s determined by an enzyme-linked immunoassay (ELISA). The anti-gp21 an
tibodies persisted for the remaining observation period, These antibod
ies were not detected in the sera from the other sheep, Absorption and
blocking experiments demonstrated the specificity of the gp21 reactiv
ity, This reactivity was also confirmed by Western blot (WB). With the
exception of the serum of an MT-2-inoculated sheep that formed a weak
band with p19 by WB, none of the sera of the four gp21-positive sheep
or of the other experimental sheep reacted with other structural or r
egulatory HTLV-I proteins, as determined by ELISA, WB, and radioimmuno
assay, PCR analyses demonstrated the presence of the HTLV-I provirus i
n peripheral blood leukocytes of the four sheep showing antibodies to
gp21(env), The remaining sheep were negative, PCR analyses failed to d
etect BLV sequences in any of the experimental sheep, None of the shee
p showed clinical abnormalities during the observation period, The pot
ential value of the sheep model for studying atypical virus-host inter
actions in infected people is discussed.